1567 related articles for article (PubMed ID: 25385233)
1. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
2. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy.
Wang Y; Liao H; Wang Y; Zhou J; Wang F; Xie Y; Zhao K; Gao W
BMC Cardiovasc Disord; 2021 May; 21(1):266. PubMed ID: 34059001
[TBL] [Abstract][Full Text] [Related]
3. Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes.
Wang Y; Huang BP; Luciani DS; Wang X; Johnson JD; Proud CG
J Mol Cell Cardiol; 2008 Dec; 45(6):812-20. PubMed ID: 18722381
[TBL] [Abstract][Full Text] [Related]
4. Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
Hille S; Dierck F; Kühl C; Sosna J; Adam-Klages S; Adam D; Lüllmann-Rauch R; Frey N; Kuhn C
Cardiovasc Res; 2016 Jun; 110(3):381-94. PubMed ID: 27056896
[TBL] [Abstract][Full Text] [Related]
5. Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
Hsieh CT; Chuang JH; Yang WC; Yin Y; Lin Y
Cell Signal; 2014 Jul; 26(7):1400-8. PubMed ID: 24650522
[TBL] [Abstract][Full Text] [Related]
6. ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb.
Blackwood EA; Hofmann C; Santo Domingo M; Bilal AS; Sarakki A; Stauffer W; Arrieta A; Thuerauf DJ; Kolkhorst FW; Müller OJ; Jakobi T; Dieterich C; Katus HA; Doroudgar S; Glembotski CC
Circ Res; 2019 Jan; 124(1):79-93. PubMed ID: 30582446
[TBL] [Abstract][Full Text] [Related]
7. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
8. The histone demethylase PHF8 represses cardiac hypertrophy upon pressure overload.
Liu X; Wang X; Bi Y; Bu P; Zhang M
Exp Cell Res; 2015 Jul; 335(1):123-34. PubMed ID: 25921086
[TBL] [Abstract][Full Text] [Related]
9. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
[TBL] [Abstract][Full Text] [Related]
10. Genetic and pharmacological inhibition of Rheb1-mTORC1 signaling exerts cardioprotection against adverse cardiac remodeling in mice.
Wu X; Cao Y; Nie J; Liu H; Lu S; Hu X; Zhu J; Zhao X; Chen J; Chen X; Yang Z; Li X
Am J Pathol; 2013 Jun; 182(6):2005-14. PubMed ID: 23567640
[TBL] [Abstract][Full Text] [Related]
11. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
Massengill MT; Ashraf HM; Chowdhury RR; Chrzanowski SM; Kar J; Warren SA; Walter GA; Zeng H; Kang BH; Anderson RH; Moss RL; Kasahara H
Cardiovasc Res; 2016 Jul; 111(1):34-43. PubMed ID: 27025239
[TBL] [Abstract][Full Text] [Related]
12. Rheb (Ras homologue enriched in brain)-dependent mammalian target of rapamycin complex 1 (mTORC1) activation becomes indispensable for cardiac hypertrophic growth after early postnatal period.
Tamai T; Yamaguchi O; Hikoso S; Takeda T; Taneike M; Oka T; Oyabu J; Murakawa T; Nakayama H; Uno Y; Horie K; Nishida K; Sonenberg N; Shah AM; Takeda J; Komuro I; Otsu K
J Biol Chem; 2013 Apr; 288(14):10176-10187. PubMed ID: 23426372
[TBL] [Abstract][Full Text] [Related]
13. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
14. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
15. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
[TBL] [Abstract][Full Text] [Related]
16. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
[TBL] [Abstract][Full Text] [Related]
19. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.
Hasumi Y; Baba M; Hasumi H; Huang Y; Lang M; Reindorf R; Oh HB; Sciarretta S; Nagashima K; Haines DC; Schneider MD; Adelstein RS; Schmidt LS; Sadoshima J; Marston Linehan W
Hum Mol Genet; 2014 Nov; 23(21):5706-19. PubMed ID: 24908670
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
